Search research articles
Contact Us
Filters
Showing results (101-110 of 214) with videos related to
Page
of 22
Sort By:
Journal of Oncology Practice
|
November 28, 2013
Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic Registry
Michael R Harrison, Bradford R Hirsch, Daniel J George, et al.
Medical Oncology (Northwood, London, England)
|
August 14, 2014
Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice
Bradford R Hirsch, Michael R Harrison, Daniel J George, et al.
Future Oncology (London, England)
|
January 17, 2024
Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
Nicholas Robert, Connie Chen, Sindy Kim, et al.
EXO : Beyond the Cell
|
April 27, 2026
Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis
Daniel Naveed Tavakol, Pamela L Graney, Meghan R Pinezich, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
ARX regulates cortical interneuron differentiation and migration
Youngshin Lim, Shyam K Akula, Abigail K Myers, et al.
American Heart Journal
|
May 15, 2018
Effects of a 12-week mHealth program on peak VO<sub>2</sub> and physical activity patterns after completing cardiac rehabilitation: A randomized controlled trial
Brian D Duscha, Lucy W Piner, Mahesh P Patel, et al.
Clinical Drug Investigation
|
August 12, 2009
Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial
Richard M Langford, Girish P Joshi, Tong J Gan, et al.
Bioengineered
|
December 29, 2023
Isolation of three different sizes of exosomes in an Asian population with different retinal diseases before and after treatment: preliminary results
Sung-Yu Wu, Yu-Chien Hung, Chien-Chih Chou, et al.
Clinical Genitourinary Cancer
|
July 17, 2013
"Real world" treatment of metastatic renal cell carcinoma in a joint community-academic cohort: progression-free survival over three lines of therapy
Michael R Harrison, Daniel J George, Mark S Walker, et al.
International Journal of Technology Assessment in Health Care
|
May 24, 2012
Incidence-based cost-of-illness model for metastatic breast cancer in the United States
Sonja V Sorensen, Jo Wern Goh, Feng Pan, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 214) with videos related to
Sort By:
Page
of 22
Journal of Oncology Practice
|
November 28, 2013
Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic Registry
Michael R Harrison, Bradford R Hirsch, Daniel J George, et al.
Medical Oncology (Northwood, London, England)
|
August 14, 2014
Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice
Bradford R Hirsch, Michael R Harrison, Daniel J George, et al.
Future Oncology (London, England)
|
January 17, 2024
Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer
Nicholas Robert, Connie Chen, Sindy Kim, et al.
EXO : Beyond the Cell
|
April 27, 2026
Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis
Daniel Naveed Tavakol, Pamela L Graney, Meghan R Pinezich, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
ARX regulates cortical interneuron differentiation and migration
Youngshin Lim, Shyam K Akula, Abigail K Myers, et al.
American Heart Journal
|
May 15, 2018
Effects of a 12-week mHealth program on peak VO<sub>2</sub> and physical activity patterns after completing cardiac rehabilitation: A randomized controlled trial
Brian D Duscha, Lucy W Piner, Mahesh P Patel, et al.
Clinical Drug Investigation
|
August 12, 2009
Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial
Richard M Langford, Girish P Joshi, Tong J Gan, et al.
Bioengineered
|
December 29, 2023
Isolation of three different sizes of exosomes in an Asian population with different retinal diseases before and after treatment: preliminary results
Sung-Yu Wu, Yu-Chien Hung, Chien-Chih Chou, et al.
Clinical Genitourinary Cancer
|
July 17, 2013
"Real world" treatment of metastatic renal cell carcinoma in a joint community-academic cohort: progression-free survival over three lines of therapy
Michael R Harrison, Daniel J George, Mark S Walker, et al.
International Journal of Technology Assessment in Health Care
|
May 24, 2012
Incidence-based cost-of-illness model for metastatic breast cancer in the United States
Sonja V Sorensen, Jo Wern Goh, Feng Pan, et al.
Page
of 22